resveratrol has been researched along with Cholera Infantum in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Apostolopoulos, V; Donald, EL; Nurgali, K; Stojanovska, L | 1 |
| Aisen, PS; Brewer, JB; Craft, S; Mintzer, J; Raman, R; Reynolds, BA; Rissman, RA; Thomas, RG; Turner, RS; van Dyck, CH | 1 |
| Carrasco-Pozo, C; Gotteland, M; Mizgier, ML; Speisky, H | 1 |
1 trial(s) available for resveratrol and Cholera Infantum
| Article | Year |
|---|---|
A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Double-Blind Method; Female; Gastrointestinal Diseases; Humans; Male; Middle Aged; Resveratrol; Stilbenes | 2015 |
2 other study(ies) available for resveratrol and Cholera Infantum
| Article | Year |
|---|---|
Resveratrol alleviates oxidative damage in enteric neurons and associated gastrointestinal dysfunction caused by chemotherapeutic agent oxaliplatin.
Topics: Animals; Antineoplastic Agents; Antioxidants; Colon; Gastrointestinal Diseases; Intestinal Mucosa; Male; Mice, Inbred BALB C; Neurons; Organoplatinum Compounds; Oxaliplatin; Oxidative Stress; Resveratrol; Stilbenes | 2017 |
Differential protective effects of quercetin, resveratrol, rutin and epigallocatechin gallate against mitochondrial dysfunction induced by indomethacin in Caco-2 cells.
Topics: Adenosine Triphosphate; Caco-2 Cells; Catechin; Drug Interactions; Electron Transport Complex I; Gastrointestinal Diseases; Humans; Indomethacin; Membrane Potential, Mitochondrial; Mitochondria; Mitochondrial Diseases; Quercetin; Resveratrol; Rutin; Stilbenes; Superoxides | 2012 |